Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payer (Details) - Customer Concentration Risk |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Net Revenue | Payer A | |||
| Accounts Receivable And Net Revenue [Line Items] | |||
| Concentration risk | 26.00% | 33.80% | 38.80% |
| Net Revenue | Payer B | |||
| Accounts Receivable And Net Revenue [Line Items] | |||
| Concentration risk | 15.60% | 13.40% | 10.10% |
| Receivables, Net and Receivables-Related Parties and Other Receivables | Payer A | |||
| Accounts Receivable And Net Revenue [Line Items] | |||
| Concentration risk | 27.40% | 38.90% | |
| Receivables, Net and Receivables-Related Parties and Other Receivables | Payer C | |||
| Accounts Receivable And Net Revenue [Line Items] | |||
| Concentration risk | 11.00% | 16.10% | |
| Receivables, Net and Receivables-Related Parties and Other Receivables | Payer D | |||
| Accounts Receivable And Net Revenue [Line Items] | |||
| Concentration risk | 18.30% | ||